Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results from the PINZ Study.

Background: The global incidence of paediatric inflammatory bowel disease (IBD) is increasing. Much of the evidence attesting to this has arisen from North America and Europe. There is a relative paucity of information on the epidemiology of paediatric IBD in the Southern Hemisphere. This study aimed to document the prospectively-collected incidence of paediatric IBD in New Zealand in 2015. Methods: All patients under 16 years of age and diagnosed with IBD in New Zealand between 1 January 2015 and 31 December 2015 were identified. Demographic and disease phenotypic details were collected and entered into a secure database. Age-specific population data for New Zealand were obtained and national incidence rates for IBD and its sub-types were calculated. Results: The prospectively-calculated incidence of paediatric IBD, Crohn's disease (CD), ulcerative colitis (UC) and inflammatory bowel disease unclassified (IBDU) in New Zealand in 2015 were 5.2 (95% CI 3.9-6.8), 3.5 (2.4-4.8), 1.0(0.5-1.8) and 0.7(0.3-1.4) per 100 000 children, respectively. Conclusions: Incidence rates of paediatric IBD in New Zealand are comparable to the highest rates published in the literature from Western Europe and North America. Ongoing prospective ascertainment of the incidence of paediatric IBD is required to better understand the environmental factors which are accounting for this increase in disease burden. (C) 2017 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology,

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2A7x1Sg
via IFTTT